AU5714801A - Methods and compositions for eliciting an immune response - Google Patents

Methods and compositions for eliciting an immune response

Info

Publication number
AU5714801A
AU5714801A AU5714801A AU5714801A AU5714801A AU 5714801 A AU5714801 A AU 5714801A AU 5714801 A AU5714801 A AU 5714801A AU 5714801 A AU5714801 A AU 5714801A AU 5714801 A AU5714801 A AU 5714801A
Authority
AU
Australia
Prior art keywords
immune response
variant
chemokine
compositions
eliciting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5714801A
Other languages
English (en)
Inventor
Thomas J Schall
Dale Talbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemocentryx Inc
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Publication of AU5714801A publication Critical patent/AU5714801A/xx
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU5714801A 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response Pending AU5714801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19883900P 2000-04-21 2000-04-21
US83481401A 2001-04-12 2001-04-12
PCT/US2001/012950 WO2001080882A2 (en) 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response

Publications (1)

Publication Number Publication Date
AU5714801A true AU5714801A (en) 2001-11-07

Family

ID=26894197

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001257148A Ceased AU2001257148B2 (en) 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response
AU5714801A Pending AU5714801A (en) 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001257148A Ceased AU2001257148B2 (en) 2000-04-21 2001-04-20 Methods and compositions for eliciting an immune response

Country Status (9)

Country Link
EP (1) EP1274454B1 (enExample)
JP (1) JP4903342B2 (enExample)
AT (1) ATE314088T1 (enExample)
AU (2) AU2001257148B2 (enExample)
CA (1) CA2406853C (enExample)
DE (1) DE60116280T2 (enExample)
DK (1) DK1274454T3 (enExample)
ES (1) ES2256232T3 (enExample)
WO (1) WO2001080882A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
WO2003035106A1 (en) * 2001-10-24 2003-05-01 Chemocentryx Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
CN101802211B (zh) 2007-08-02 2014-10-01 诺维莫尼公司 抗正常t细胞表达和分泌活化调节因子(rantes)抗体及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE424217T1 (de) * 1997-12-11 2009-03-15 Univ Maryland Biotech Inst Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
WO1999043839A1 (en) * 1998-02-27 1999-09-02 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same
EP1073749B1 (en) * 1998-04-22 2006-01-11 Chiron Corporation Enhancing immune responses to genetic immunization by using a chemokine

Also Published As

Publication number Publication date
EP1274454B1 (en) 2005-12-28
ES2256232T3 (es) 2006-07-16
DE60116280T2 (de) 2006-09-21
JP2003534250A (ja) 2003-11-18
CA2406853A1 (en) 2001-11-01
CA2406853C (en) 2012-06-26
ATE314088T1 (de) 2006-01-15
WO2001080882A3 (en) 2002-04-04
DE60116280D1 (de) 2006-02-02
DK1274454T3 (da) 2006-05-15
JP4903342B2 (ja) 2012-03-28
AU2001257148B2 (en) 2006-03-30
EP1274454A2 (en) 2003-01-15
WO2001080882A2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
IT1200176B (it) Struttura per poltrone con sedile e schienale mobili, in particolare per uso odontoiatrico
MXPA04000982A (es) Metodos para movilizar celulas progenitoras/madre.
NO20013875L (no) Modning av dendrittiske celler med immunresponsmodifiserende forbindelse
DE69637942D1 (de) Stimulationsfaktor für dendriten
MXPA05013973A (es) Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos.
PL343245A1 (en) Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
ES2062330T3 (es) Conjugados.
WO2001080887A3 (en) Methods and chemokin compositions for inducing an immune response
WO2001068697A3 (en) Methods and compositions for immunoregulation
NZ507829A (en) Vaccine adjuvants for immunotherapy of melanoma
AU4791901A (en) Compositions and methods for dendritic cell-based immunotherapy
AU5714801A (en) Methods and compositions for eliciting an immune response
NZ511445A (en) Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
DE69133159D1 (de) Chemotaktische faktoren
AU3823601A (en) Cytotoxic t lymphocytes activated by dendritic cell hybrids
DE69835615D1 (de) Induzierte zelluläre immunitität durch aktivierung der th1 und unterdrückung der th2 antwort durch macrophhagen
EP1447414A3 (en) Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
EP1198012A3 (en) Surface cladding element comprising a photovoltaic cell
WO2000051630A3 (en) Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent
WO2002040044A3 (en) Chemoattractant recruitment of dendritic cells for enhancement of immunization
IT8604937V0 (it) Struttura per poltrone con sedile e schienale mobili in particolare per uso odontoiatrico
주성수 et al. Effect of Pedunculagin in production of TNF-αof Langerhans Cells
ITBS930058A0 (it) Perfezionamento del dispositivo adatto per regolare la posizione in altezza dello schienale di sedie e poltrone
ITBS920083V0 (it) Bottone per cuscini di poltrone divani e sedute in generale
MD Developing Immunomodulators: IL-12 and ONO-4007